The chemical structure of tranexamic acid is similar to lysine, competitive inhibition of plasmin original in fibrin adsorption, to prevent their activation, protection fiber protein not to degrade by plasmin and dissolve, eventually achieve hemostasis. Applicable in the treatment of acute or chronic, localized or systemic primary fiber fibrinolytic hyperthyroidism caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hemorrhage of hypertrophy of the prostate, hemophilia, pulmonary tuberculosis hemoptysis, stomach bleeding, after operation of liver, lung, spleen and other viscera hemorrhage; also can be used in surgery when abnormal bleeding etc..
Clinical tranexamic acid has effect significantly to insect bites disease, dermatitis and eczema, simple purpura, chronic urticaria, artificial sex urticaria, toxic eruption and eruption. And also has a certain effect on erythroderma, scleroderma, systemic lupus erythematosus (SLE), Erythema multiforme, shingles and alopecia areata. Treatment of hereditary angioedema effect is also good. In the treatment of Chloasma, general medicine is effective about 3 weeks, markedly effective 5 weeks, a course of 60 days. Given orally in doses of 0.25 ~ 0.5 g, a day 3 ~ 4 times. A few patients can nausea, fatigue, pruritus, abdominal discomfort, and diarrhea side effects after withdrawal symptoms disappear.
1.Tranexamic acid is mainly used for various types of bleeding caused by acute or chronic, localized or systemic fibrinolysis.
2. The melamine-removing effect of tranexamic acid is about 50 times higher than vitamin C and nearly 10 times that of fruit acid, so it can also be used for skin whitening.
3. Pay attention to the secondary high fibrinolysis state caused by disseminated intravascular coagulation, and use this product with caution before heparinization.
Waxaan leenahay warshado badan oo tayo sare leh oo leh iskaashi qoto dheer, kuwaas oo ku siin kara alaab tayo sare leh iyo qiimo tartan leh. Waxaan sidoo kale ku siin karnaa qiimo-dhimis iibsasho badan. Oo waxaanu la shaqaynaa shirkado badan oo soo gudbiya xamuulka, waxaanu u gaarsiin karnaa alaabta si badbaado leh oo qumman gacmahaaga. Waqtiga bixinta waa qiyaastii 3-20 maalmood kadib xaqiijinta lacag bixinta.
Shayga | Tilmaamid | Test Results |
Muuqashada | White powder, neutral odor, highly hygroscopic | U hoggaansamo |
Aqoonsiga | TLC:Standard solution and test solution same spot,RF | U hoggaansamo |
Assay (Dry Basis) | 98.0%--102.0% | 100.98% |
Specific Optical | -2.4°~ -2.8° | -2.71° |
PH | 4.5~7.0 | 5.3 |
Heavy Metals (As Pb) | ≤10ppm | <10ppm |
Sida | ≤1ppm | Not Detected |
Pb | ≤0.5ppm | Not Detected |
Cd | ≤1ppm | Not Detected |
Hg | ≤0.1ppm | Not Detected |
Related substance | Spot not bigger than standard solution spot |
No spot |
Residual solvent | <0.5% | U hogaansama |
Water Content | <2% | 0.18% |
Tranexamic acid is a White or almost white, crystalline powder. It is freely soluble in water and in glacial acetic acid and is very slightly soluble in ethanol and practically insoluble in ether. Tranexamic acid is an antifibrinolytic agent and is commonly used for heavy menstrual bleeding. Tranexamic acid is a monocarboxylic acid. It has a role as an antifibrinolytic drug and a hematologic agent. It is functionally related to a cyclohexanecarboxylic acid.
Uses
Fibrinolysis, the cleavage of fibrin by plasmin, is a normal step in the dissolution of fibrin clots after wound repair. Tranexamic acid is an inhibitor of fibrinolysis that blocks the interaction of plasmin with fibrin (IC50 = 3.1 μM). It is a lysine mimetic that binds the lysine binding site in plasmin. Antifibrinolytic agents have value when fibrinolytic activity is abnormally high or when coagulation is impaired.
Various bleedings caused by acute or chronic, localized or systemic primary hyperfibrinolysis; secondary hyperfibrinolytic state caused by disseminated intravascular coagulation. Generally do not use this product before heparinization.
Trauma or surgical bleeding in tissue and organs with abundant plasminogen activators such as prostate, urethra, lung, brain, uterus, adrenal glands, and thyroid.
1. Ma waxaad tahay warshad ama shirkad ganacsi?
Waxaan nahay shirkad isku-dhafan oo warshado iyo ganacsi ah, oo bixisa adeeg hal-joojin ah. OEM waa la aqbali karaa.
2. Ma bixisaa muunado? Ma bilaash baa mise waa dheeraad?
Muunado bilaash ah. Kharashka xamuulka ee muunada waxa loo baahan yahay in dhinacaaga laga bixiyo.
3. Ma haysaa wax shahaado ah oo la xidhiidha ilaalinta tayada?
ISO 9001: 2008 shahaado si loo hubiyo tayada.
4. Maxaan bixiyaa si aan u helo xigasho?
Pls noo soo sheeg nooca badeecada aad u baahan tahay, dalbo tirada, ciwaanka iyo shuruudaha gaarka ah
5. Habka lacag-bixinta noocee ah ayaad doorbidaysaa? Waa maxay nooca shuruudaha la aqbalo?
Shuruudaha keenista la aqbalay: FOB, CFR, CIF, EXW;
Lacagta Bixinta La Oggolyahay: USD;
Nooca Lacag-bixinta La Aqbalay: T/T,Ururka Galbeedka; Paypal, Hubinta Ganacsiga.
Luuqadaha lagu hadlo: Ingiriis.
Qaybaha alaabta